These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.


BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

293 related articles for article (PubMed ID: 21079811)

  • 1. ER-α36, a novel variant of ER-α, mediates estrogen-stimulated proliferation of endometrial carcinoma cells via the PKCδ/ERK pathway.
    Tong JS; Zhang QH; Wang ZB; Li S; Yang CR; Fu XQ; Hou Y; Wang ZY; Sheng J; Sun QY
    PLoS One; 2010 Nov; 5(11):e15408. PubMed ID: 21079811
    [TBL] [Abstract][Full Text] [Related]  

  • 2. ER-alpha36, a variant of ER-alpha, promotes tamoxifen agonist action in endometrial cancer cells via the MAPK/ERK and PI3K/Akt pathways.
    Lin SL; Yan LY; Zhang XT; Yuan J; Li M; Qiao J; Wang ZY; Sun QY
    PLoS One; 2010 Feb; 5(2):e9013. PubMed ID: 20126312
    [TBL] [Abstract][Full Text] [Related]  

  • 3. A novel variant of ER-alpha, ER-alpha36 mediates testosterone-stimulated ERK and Akt activation in endometrial cancer Hec1A cells.
    Lin SL; Yan LY; Liang XW; Wang ZB; Wang ZY; Qiao J; Schatten H; Sun QY
    Reprod Biol Endocrinol; 2009 Sep; 7():102. PubMed ID: 19775474
    [TBL] [Abstract][Full Text] [Related]  

  • 4. ER-α36, a novel variant of estrogen receptor α, is involved in EGFR-related carcinogenesis in endometrial cancer.
    Tu BB; Lin SL; Yan LY; Wang ZY; Sun QY; Qiao J
    Am J Obstet Gynecol; 2011 Sep; 205(3):227.e1-6. PubMed ID: 21684519
    [TBL] [Abstract][Full Text] [Related]  

  • 5. Estrogen receptor-α variant, ER-α36, is involved in tamoxifen resistance and estrogen hypersensitivity.
    Zhang X; Wang ZY
    Endocrinology; 2013 Jun; 154(6):1990-8. PubMed ID: 23546601
    [TBL] [Abstract][Full Text] [Related]  

  • 6. ER-α36 mediates estrogen-stimulated MAPK/ERK activation and regulates migration, invasion, proliferation in cervical cancer cells.
    Sun Q; Liang Y; Zhang T; Wang K; Yang X
    Biochem Biophys Res Commun; 2017 Jun; 487(3):625-632. PubMed ID: 28435071
    [TBL] [Abstract][Full Text] [Related]  

  • 7. Estrogen activation of the mitogen-activated protein kinase is mediated by ER-α36 in ER-positive breast cancer cells.
    Zhang X; Deng H; Wang ZY
    J Steroid Biochem Mol Biol; 2014 Sep; 143():434-43. PubMed ID: 24973581
    [TBL] [Abstract][Full Text] [Related]  

  • 8. ER-α36 mediates cisplatin resistance in breast cancer cells through EGFR/HER-2/ERK signaling pathway.
    Zhu L; Zou J; Zhao Y; Jiang X; Wang Y; Wang X; Chen B
    J Exp Clin Cancer Res; 2018 Jun; 37(1):123. PubMed ID: 29940998
    [TBL] [Abstract][Full Text] [Related]  

  • 9. Synuclein gamma stimulates membrane-initiated estrogen signaling by chaperoning estrogen receptor (ER)-alpha36, a variant of ER-alpha.
    Shi YE; Chen Y; Dackour R; Potters L; Wang S; Ding Q; Wang Z; Liu YE
    Am J Pathol; 2010 Aug; 177(2):964-73. PubMed ID: 20595634
    [TBL] [Abstract][Full Text] [Related]  

  • 10. A variant of estrogen receptor-{alpha}, hER-{alpha}36: transduction of estrogen- and antiestrogen-dependent membrane-initiated mitogenic signaling.
    Wang Z; Zhang X; Shen P; Loggie BW; Chang Y; Deuel TF
    Proc Natl Acad Sci U S A; 2006 Jun; 103(24):9063-8. PubMed ID: 16754886
    [TBL] [Abstract][Full Text] [Related]  

  • 11. Estrogen receptor-α36 is involved in pterostilbene-induced apoptosis and anti-proliferation in in vitro and in vivo breast cancer.
    Pan C; Hu Y; Li J; Wang Z; Huang J; Zhang S; Ding L
    PLoS One; 2014; 9(8):e104459. PubMed ID: 25127034
    [TBL] [Abstract][Full Text] [Related]  

  • 12. Estrogen receptor-α36 is involved in development of acquired tamoxifen resistance via regulating the growth status switch in breast cancer cells.
    Li G; Zhang J; Jin K; He K; Zheng Y; Xu X; Wang H; Wang H; Li Z; Yu X; Teng X; Cao J; Teng L
    Mol Oncol; 2013 Jun; 7(3):611-24. PubMed ID: 23499324
    [TBL] [Abstract][Full Text] [Related]  

  • 13. G protein-coupled receptor 30-dependent protein kinase A pathway is critical in nongenomic effects of estrogen in attenuating liver injury after trauma-hemorrhage.
    Hsieh YC; Yu HP; Frink M; Suzuki T; Choudhry MA; Schwacha MG; Chaudry IH
    Am J Pathol; 2007 Apr; 170(4):1210-8. PubMed ID: 17392161
    [TBL] [Abstract][Full Text] [Related]  

  • 14. Involvement of estrogen receptor variant ER-alpha36, not GPR30, in nongenomic estrogen signaling.
    Kang L; Zhang X; Xie Y; Tu Y; Wang D; Liu Z; Wang ZY
    Mol Endocrinol; 2010 Apr; 24(4):709-21. PubMed ID: 20197310
    [TBL] [Abstract][Full Text] [Related]  

  • 15. Biphasic ER-α36-mediated estrogen signaling regulates growth of gastric cancer cells.
    Wang X; Huang X; Fu Z; Zou F; Li Y; Wang Z; Liu L
    Int J Oncol; 2014 Dec; 45(6):2325-30. PubMed ID: 25231129
    [TBL] [Abstract][Full Text] [Related]  

  • 16. Estrogen receptor-α36 is involved in icaritin induced growth inhibition of triple-negative breast cancer cells.
    Wang X; Zheng N; Dong J; Wang X; Liu L; Huang J
    J Steroid Biochem Mol Biol; 2017 Jul; 171():318-327. PubMed ID: 28529129
    [TBL] [Abstract][Full Text] [Related]  

  • 17. ER-alpha36, a novel variant of ER-alpha, is expressed in ER-positive and -negative human breast carcinomas.
    Lee LM; Cao J; Deng H; Chen P; Gatalica Z; Wang ZY
    Anticancer Res; 2008; 28(1B):479-83. PubMed ID: 18383888
    [TBL] [Abstract][Full Text] [Related]  

  • 18. Estrogen receptor-alpha 36 mediates mitogenic antiestrogen signaling in ER-negative breast cancer cells.
    Zhang X; Ding L; Kang L; Wang ZY
    PLoS One; 2012; 7(1):e30174. PubMed ID: 22276155
    [TBL] [Abstract][Full Text] [Related]  

  • 19. [Nongenomic effects of estrogen on extracellular signal-regulated kinases through initiating transient calcium flux in endometrial cancer].
    Zhang LL; Wang JL
    Beijing Da Xue Xue Bao Yi Xue Ban; 2015 Jun; 47(3):489-93. PubMed ID: 26080881
    [TBL] [Abstract][Full Text] [Related]  

  • 20. [Estradiol activates MAPK signaling pathway by estrogen induced VEGF and bFGF in endometrial cancer cells].
    Lu Y; Jiang S; Zhang J; Song H; Li L
    Zhonghua Fu Chan Ke Za Zhi; 2014 Dec; 49(12):925-31. PubMed ID: 25608994
    [TBL] [Abstract][Full Text] [Related]  

    [Next]    [New Search]
    of 15.